139 related articles for article (PubMed ID: 31242404)
1. Integrin beta 4 (ITGB4) and its tyrosine-1510 phosphorylation promote pancreatic tumorigenesis and regulate the MEK1-ERK1/2 signaling pathway.
Meng X; Liu P; Wu Y; Liu X; Huang Y; Yu B; Han J; Jin H; Tan X
Bosn J Basic Med Sci; 2020 Feb; 20(1):106-116. PubMed ID: 31242404
[TBL] [Abstract][Full Text] [Related]
2. Analysis of invasion-metastasis mechanism in pancreatic cancer: involvement of tight junction transmembrane protein occludin and MEK/ERK signal transduction pathway in cancer cell dissociation.
Tan X; Tamori Y; Egami H; Ishikawa S; Kurizaki T; Takai E; Hirota M; Ogawa M
Oncol Rep; 2004 May; 11(5):993-8. PubMed ID: 15069537
[TBL] [Abstract][Full Text] [Related]
3. Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
Mol Cancer; 2005 Oct; 4():37. PubMed ID: 16209712
[TBL] [Abstract][Full Text] [Related]
4. The RON-receptor regulates pancreatic cancer cell migration through phosphorylation-dependent breakdown of the hemidesmosome.
Yu PT; Babicky M; Jaquish D; French R; Marayuma K; Mose E; Niessen S; Hoover H; Shields D; Cheresh D; Cravatt BF; Lowy AM
Int J Cancer; 2012 Oct; 131(8):1744-54. PubMed ID: 22275185
[TBL] [Abstract][Full Text] [Related]
5. Netrin-1 suppresses the MEK/ERK pathway and ITGB4 in pancreatic cancer.
An XZ; Zhao ZG; Luo YX; Zhang R; Tang XQ; Hao D; Zhao X; Lv X; Liu D
Oncotarget; 2016 Apr; 7(17):24719-33. PubMed ID: 27034160
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of Gli transcription factor leads to the inhibition of migration and invasion of ovarian cancer cells via integrin β4-mediated FAK signaling.
Chen Q; Xu R; Zeng C; Lu Q; Huang D; Shi C; Zhang W; Deng L; Yan R; Rao H; Gao G; Luo S
PLoS One; 2014; 9(2):e88386. PubMed ID: 24533083
[TBL] [Abstract][Full Text] [Related]
7. Metallopanstimulin-1 regulates invasion and migration of gastric cancer cells partially through integrin β4.
Yang ZY; Jiang H; Qu Y; Wei M; Yan M; Zhu ZG; Liu BY; Chen GQ; Wu YL; Gu QL
Carcinogenesis; 2013 Dec; 34(12):2851-60. PubMed ID: 23803695
[TBL] [Abstract][Full Text] [Related]
8. Relationship between activation of epidermal growth factor receptor and cell dissociation in pancreatic cancer.
Tan X; Egami H; Ishikawa S; Nakagawa M; Ishiko T; Kamohara H; Hirota M; Ogawa M
Int J Oncol; 2004 Nov; 25(5):1303-9. PubMed ID: 15492819
[TBL] [Abstract][Full Text] [Related]
9. Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway.
Baril P; Gangeswaran R; Mahon PC; Caulee K; Kocher HM; Harada T; Zhu M; Kalthoff H; Crnogorac-Jurcevic T; Lemoine NR
Oncogene; 2007 Mar; 26(14):2082-94. PubMed ID: 17043657
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic role of TYRO3 receptor tyrosine kinase in the progression of pancreatic cancer.
Morimoto M; Horikoshi Y; Nakaso K; Kurashiki T; Kitagawa Y; Hanaki T; Sakamoto T; Honjo S; Umekita Y; Fujiwara Y; Matsura T
Cancer Lett; 2020 Feb; 470():149-160. PubMed ID: 31765735
[TBL] [Abstract][Full Text] [Related]
11. The Ras-ERK1/2 signaling pathway regulates H3K9ac through PCAF to promote the development of pancreatic cancer.
Li YH; Li YX; Li M; Song SW; Ge Y; Jin JY; Li XY; Tan XD; Ye J
Life Sci; 2020 Sep; 256():117936. PubMed ID: 32531376
[TBL] [Abstract][Full Text] [Related]
12. The transcription factor HOXB7 regulates ERK kinase activity and thereby stimulates the motility and invasiveness of pancreatic cancer cells.
Tsuboi M; Taniuchi K; Shimizu T; Saito M; Saibara T
J Biol Chem; 2017 Oct; 292(43):17681-17702. PubMed ID: 28912272
[No Abstract] [Full Text] [Related]
13. An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway.
Leng C; Zhang ZG; Chen WX; Luo HP; Song J; Dong W; Zhu XR; Chen XP; Liang HF; Zhang BX
Cancer Lett; 2016 Jun; 376(1):188-96. PubMed ID: 26996299
[TBL] [Abstract][Full Text] [Related]
14. CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation.
Miyazawa Y; Uekita T; Hiraoka N; Fujii S; Kosuge T; Kanai Y; Nojima Y; Sakai R
Cancer Res; 2010 Jun; 70(12):5136-46. PubMed ID: 20501830
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the mitogen-activated protein kinase kinase 2 in the induction of cell dissociation in pancreatic cancer.
Tan X; Egami H; Kamohara H; Ishikawa S; Kurizaki T; Yoshida N; Tamori Y; Takai E; Hirota M; Ogawa M
Int J Oncol; 2004 Jan; 24(1):65-73. PubMed ID: 14654942
[TBL] [Abstract][Full Text] [Related]
16. Convergence of eicosanoid and integrin biology: 12-lipoxygenase seeks a partner.
Tang K; Cai Y; Joshi S; Tovar E; Tucker SC; Maddipati KR; Crissman JD; Repaskey WT; Honn KV
Mol Cancer; 2015 Jun; 14():111. PubMed ID: 26037302
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix protein 1 promotes cell metastasis and glucose metabolism by inducing integrin β4/FAK/SOX2/HIF-1α signaling pathway in gastric cancer.
Gan L; Meng J; Xu M; Liu M; Qi Y; Tan C; Wang Y; Zhang P; Weng W; Sheng W; Huang M; Wang Z
Oncogene; 2018 Feb; 37(6):744-755. PubMed ID: 29059156
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
[TBL] [Abstract][Full Text] [Related]
19. Zonula occludens-1 (ZO-1) redistribution is involved in the regulation of cell dissociation in pancreatic cancer cells.
Tan X; Egami H; Ishikawa S; Kurizaki T; Hirota M; Ogawa M
Dig Dis Sci; 2005 Aug; 50(8):1402-9. PubMed ID: 16110828
[TBL] [Abstract][Full Text] [Related]
20. KRAS Mutants Upregulate Integrin β4 to Promote Invasion and Metastasis in Colorectal Cancer.
Choi SH; Kim JK; Chen CT; Wu C; Marco MR; Barriga FM; O'Rourke K; Pelossof R; Qu X; Chang Q; de Stanchina E; Shia J; Smith JJ; Sanchez-Vega F; Garcia-Aguilar J
Mol Cancer Res; 2022 Aug; 20(8):1305-1319. PubMed ID: 35394541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
